Hildebrandt P - Search Results

1

N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.

Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt P. Olsen MH, et al. Among authors: hildebrandt p. J Hypertens. 2004 Aug;22(8):1597-604. doi: 10.1097/01.hjh.0000125451.28861.2a. J Hypertens. 2004. PMID: 15257184 Clinical Trial.

2

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jørgensen T, Hildebrandt P. Olsen MH, et al. Among authors: hildebrandt p. Hypertension. 2005 Oct;46(4):660-6. doi: 10.1161/01.HYP.0000179575.13739.72. Epub 2005 Aug 29. Hypertension. 2005. PMID: 16129819

3

High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.

Olsen MH, Christensen MK, Hansen TW, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jørgensen T, Hildebrandt P. Olsen MH, et al. Among authors: hildebrandt p. J Hypertens. 2006 Apr;24(4):655-61. doi: 10.1097/01.hjh.0000217847.03208.ba. J Hypertens. 2006. PMID: 16531793

4

Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.

Christensen MK, Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Wiinberg N, Devereux RB, Kjeldsen SE, Hildebrandt P, Rokkedal J, Ibsen H. Christensen MK, et al. Among authors: hildebrandt p. Blood Press. 2006;15(4):198-206. doi: 10.1080/08037050600962968. Blood Press. 2006. PMID: 17078155 Free article. Clinical Trial.

5

N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis.

Hildebrandt P, Boesen M, Olsen M, Wachtell K, Groenning B. Hildebrandt P, et al. Eur J Heart Fail. 2004 Mar 15;6(3):313-7. doi: 10.1016/j.ejheart.2004.01.001. Eur J Heart Fail. 2004. PMID: 14987582 Free article.

6

Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.

Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt PR. Olsen MH, et al. J Hypertens. 2005 May;23(5):1083-90. doi: 10.1097/01.hjh.0000166851.18463.85. J Hypertens. 2005. PMID: 15834296 Clinical Trial.

7

N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR. Olsen MH, et al. J Hypertens. 2006 Aug;24(8):1531-9. doi: 10.1097/01.hjh.0000239288.10013.04. J Hypertens. 2006. PMID: 16877955 Clinical Trial.

8

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR. Olsen MH, et al. Eur Heart J. 2007 Jun;28(11):1374-81. doi: 10.1093/eurheartj/ehl448. Epub 2007 Jan 22. Eur Heart J. 2007. PMID: 17242007

9

Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR. Olsen MH, et al. J Hypertens. 2008 Jan;26(1):26-34. doi: 10.1097/HJH.0b013e3282f18301. J Hypertens. 2008. PMID: 18090537

10

Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?

Olsen MH, Sehestedt T, Lyngbaek S, Hansen TW, Rasmussen S, Wachtell K, Torp-Pedersen C, Hildebrandt PR, Ibsen H. Olsen MH, et al. Curr Vasc Pharmacol. 2010 Jan;8(1):134-9. doi: 10.2174/157016110790226633. Curr Vasc Pharmacol. 2010. PMID: 19485906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters